Peer Review History
| Original SubmissionSeptember 3, 2025 |
|---|
|
Dear Dr. Vesna Bacheva, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 18 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Fentahun Adane Nigat, MSc., PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating in your Funding Statement: “National Science Foundation STC Center for Research on Programmable Plant System under grant number DBI-2019674. V. Bacheva was supported by Schmidt Science Fellows, SNF Postdoc.Mobility (grant number 214477), and KIC Postdoctoral Fellowship” Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 3. Thank you for stating the following financial disclosure: “National Science Foundation STC Center for Research on Programmable Plant System under grant number DBI-2019674. V. Bacheva was supported by Schmidt Science Fellows, SNF Postdoc.Mobility (grant number 214477), and KIC Postdoctoral Fellowship” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.] Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. 5. Thank you for stating the following in the Acknowledgments Section of your manuscript: “This project was supported by the National Science Foundation STC Center for Research on Programmable Plant System under grant number DBI-2019674. V. Bacheva was supported by Schmidt Science Fellows, SNF Postdoc.Mobility (grant number 214477), and KIC Postdoctoral Fellowship” We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “National Science Foundation STC Center for Research on Programmable Plant System under grant number DBI-2019674. V. Bacheva was supported by Schmidt Science Fellows, SNF Postdoc.Mobility (grant number 214477), and KIC Postdoctoral Fellowship” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 6. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments (if provided): Thank you for submitting your manuscript entitled “Low-cost, DIY programmable tissue processor for solvent exchange in biological sample preparation” to PLOS ONE. The reviewers and I recognize the novelty and practical relevance of your work, which presents an innovative and potentially impactful approach to affordable, open-source laboratory automation. However, several critical issues must be addressed before the manuscript can be reconsidered for publication. Manuscript structure and organization The current version does not fully adhere to the journal’s required structure. Please revise the manuscript to include clearly defined sections—Introduction, Materials and Methods, Results, Discussion, and Conclusion—with logical flow and sufficient methodological detail. Ensure that limitations are clearly discussed. Title and scope Revise the title to better reflect the evaluative and experimental nature of the study. For example, a title such as “Evaluation of a Low-Cost, DIY Programmable Tissue Processor for Solvent Exchange in Biological Sample Preparation” would more accurately convey the focus on device performance. Validation of the software and hardware Provide experimental validation data for both the control software and hardware system. This should include: Software reliability: accuracy of timing and sequencing, error-handling capacity, and reproducibility. Hardware performance: comparison with a commercial or standard tissue processor in terms of tissue quality, staining uniformity, and solvent exchange efficiency. Quantitative results and appropriate statistical analyses should be presented to support the device’s claimed performance. Quantitative performance assessment Include clear performance metrics such as processing time, solvent exchange rate, and reproducibility across multiple runs. Comparative data will strengthen the technical credibility of the device. Statistical and experimental details Please specify the number of replicates (n), the statistical tests used, and any measures of variability (e.g., mean ± SD). These additions are necessary to validate reproducibility and reliability. Safety, scalability, and reproducibility Add a section discussing safety considerations (e.g., solvent vapor management) and the device’s scalability, including its ability to process multiple samples simultaneously. Mention expected lifespan and maintenance requirements for key components. Context and literature Expand the Introduction to include comparative context with other open-source automation tools (e.g., OpenTrons, microfluidic systems). Clarify the unique innovation of your design (e.g., whether it automates both dehydration and rehydration steps). Figures, tables, and data presentation Ensure all figures have complete legends, proper scale bars, and consistent numbering. Tables should include total cost estimates and availability of components. Verify that all figures are cited sequentially in the text. Language, formatting, and references Conduct a thorough grammatical and editorial revision to improve clarity and professional tone. Ensure consistent formatting of units, symbols, and reference style, and include DOIs for all references where possible. Additional scientific context As noted by one reviewer, please mention in the Introduction that imaging techniques are used not only for examining cell growth and responses but also for assessing cell death, to provide a more comprehensive context for the use of tissue imaging. Once these revisions are completed, please provide: A revised manuscript with all corrections clearly highlighted or tracked, and A detailed point-by-point response addressing each reviewer comment and editorial note. We believe that, with substantial revision and additional validation, this study could make a meaningful contribution to the field of open-source biomedical instrumentation. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No Reviewer #2: No Reviewer #3: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: Manuscript title: Low-cost, DIY programmable tissue processor for solvent exchange in biological sample preparation General comments: Thank you for the opportunity to review this manuscript, which presents a novel and potentially valuable low-cost, DIY programmable tissue processor. The concept is highly relevant, as accessible and affordable instrumentation can significantly advance biological and medical researches. However, in its current form, the manuscript requires major revision before it can be considered for publication. The main drawbacks are lack of structural rigor and insufficient validation data. The following major flaws must be addressed to meet the scientific standards expected by this journal. 1. The current title is descriptive but does not accurately reflect the evaluative nature of the work that is required for a scientific publication. It should be revised to emphasize the performance assessment of the device. Consider a title such as ‘Evaluation of a Low-Cost, DIY Programmable Tissue Processor for Solvent Exchange in Biological Sample Preparation’. 2. The manuscript does not adhere to the standard structure (e.g., Introduction, Methods, Results, Discussion, Conclusion) required by the journal. The absence of clearly defined sections for Methods, Results, and a Discussion that without the study limitations makes it difficult to assess the validity and scope of the work. The manuscript must be thoroughly reorganized to meet these fundamental publication standards. 3. A critical omission is the validation of the custom-developed software. The manuscript should include data demonstrating the software's reliability, such as Accuracy- Does the software execute the programmed timing and sequence steps correctly and consistently? Error Handling - How does the software manage user input errors or hardware communication failures? Reproducibility- Are the programmed protocols reproducible across multiple runs and by different users? 4. The study lacks a quantitative performance evaluation of the hardware itself. To establish the device's utility, it is essential to compare its performance against a commercial or standard benchmark. This analysis should include: - Sensitivity- can the device consistently and effectively process a range of tissue types and sizes to a high-quality standard? Specificity/Robustness- are the results free from artifacts introduced by the device? Data comparing tissue morphology, staining quality, and processing consistency (e.g., against a commercial processor) is necessary. Performance Metrics- include data on processing time, solvent exchange efficiency, and consistency of results across multiple batches. 5. The authors are strongly encouraged to perform a comprehensive revision of the manuscript, ensuring it fully aligns with all specific formatting and content guidelines for the journal (PLOS ONE). This includes the incorporation of all standard scientific manuscript sections, a clear description of limitations, and the critical validation data outlined above. Reviewer #2: Comments to the authors: Title: “Low-cost, DIY programmable tissue processor for solvent exchange in biological sample preparation” Manuscript Number: (PONE-D-25-48079) Dear the editor of PLOS ONE Journal I would like to express my sincere gratitude for the opportunity to review this manuscript and contribute my expertise to the advancement of scientific knowledge. I also wish to extend my appreciation to the authors for their valuable contribution in exploring an innovative and time-efficient technology for tissue processing. Their work addresses a significant need in histological research and diagnostics by proposing a method that has the potential to reduce the time, labor, and resource demands traditionally associated with conventional tissue processing procedures. 1. Title: “Low-cost, DIY programmable tissue processor for solvent exchange in biological sample preparation” (PONE-D-25-48079): • Comment: The title is concise, descriptive, and captures the core innovation of the work “low-cost,” “DIY,” and “programmable” are strong keywords that attract interest in open-source hardware and biological sample preparation. • Suggestions: o Consider specifying the type of tissues or applications (e.g., “for histological and fluorescence microscopy sample preparation”) to make the scope clearer. o Describe the “DIY” first and make formal contexts since journals like PLOS ONE prefer academic tone. 2. Abstract • Comment: The abstract clearly summarizes the motivation, approach, design, and findings. It effectively emphasizes accessibility and cost reduction. • Suggestions: o The problem statement could briefly include quantitative efficiency (e.g., percentage reduction in manual time). o Add a brief mention of validation results (e.g., comparable fluorescence intensity to manual staining). 3. Introduction • Comment: The introduction is well structured, providing a logical flow from biological imaging needs to limitations of existing systems and the motivation for a low-cost alternative. References (1–16) are appropriate and current. • Suggestions: o Include a comparative statement with similar open-source automation tools (e.g., OpenTrons or other microfluidic DIY devices). o Add a clear hypothesis or research question at the end of the section (e.g., “We hypothesize that a low-cost programmable tissue processor can achieve staining results equivalent to commercial systems”). o Clarify the novelty, does the processor uniquely automate both dehydration and rehydration steps or simply adapt existing robotics principles? o Check citation consistency (e.g., space before parentheses: “subsequent tissue clearing(6)” → “subsequent tissue clearing (6)”). 4. Design of the Automated Tissue Processor • Comment: This section provides excellent technical clarity. Figures 1–2 support understanding. • Suggestions: o Include a brief cost breakdown within this section, not only in Table 1, to strengthen the claim of affordability. o A risk assessment or safety note (e.g., ethanol vapor management) could improve completeness. o Clarify scalability, can this handle multiple samples simultaneously? o Add comparison with existing low-cost automation platforms for context (e.g., Arduino-controlled microfluidic systems). 5. Software Design and Operation • Comment: Comprehensive description of the user interface and operational logic. The inclusion of a flowchart (Fig. 3) is excellent. • Suggestions: • Indicate whether the software includes error handling or alerts (e.g., empty solvent reservoirs). • Consider including code versioning or repository DOI earlier for transparency. • A short subsection on usability testing (who tested it, user feedback) could strengthen reproducibility claims. 6. Performance of the Tissue Processor • Comment: Validation using propidium iodide (PI) staining on multiple plant species is appropriate and convincing. Quantitative fluorescence comparison (signal-to-noise ratio ~80) supports equivalency. • Suggestions: o Include statistical analysis (e.g., t-test comparing mean intensity between manual and automated samples). o Provide replicate numbers (n) for reproducibility. o Add discussion on long-term performance or maintenance stability (e.g., after repeated use). o Minor: specify microscope model consistently (e.g., “Zeiss LSM 880 confocal microscope” should appear consistently, not “Zeiss u880”). 7. Design Considerations • Comment: Good rationale for material and component selection. • Suggestions: o Add a table of solvent compatibility for quick reference. o Include expected lifespan or maintenance recommendations for pumps and valves. o Clarify whether temperature or humidity control is needed for reliable operation. o Mention possible future modifications (e.g., incorporation of sensors or remote data logging). 8. Conclusion • Comment: The conclusion effectively summarizes the study’s achievements and potential applications. • Suggestions: o Add a quantitative summary (e.g., cost reduction, processing time, and staining reproducibility). o End with a forward-looking statement about potential expansion to animal tissues or integration with automated imaging systems. Example: “Future work could extend this platform to integrate real-time imaging or temperature-controlled sample handling.” 9. Materials and Methods • Comment: Extremely detailed and well written, especially for reproducibility. The use of open-source files and a GitHub repository aligns with PLOS ONE’s data policy. • Suggestions: o For clarity, include subheadings under “Assembly Procedure” (e.g., “Control Box,” “Pump Module”). o Add a short note on ethical or biosafety considerations if using plant materials. o Ensure units and symbols follow consistent formatting (e.g., “°C,” “μm”). o In “Electrical wiring,” specify any safety isolation between power and control circuits. o Table 1 could include total estimated cost and country availability of parts. 10. Figures and Tables • Comment: Figures are clear and informative. Table 1–3 provide high transparency. • Suggestions: o Ensure all figures include scale bars for microscopy images. o Figures 1 and 7: add legends with abbreviations for clarity. o Combine Fig. 2 (pump calibration) and a small chart comparing manual vs. automated results for visual impact. o Verify all figure numbers are cited in the text sequentially. 11. References • Comment: The reference list is recent, relevant, and includes both foundational and contemporary studies (e.g., PLOS ONE 2024 papers). • Suggestions: o Ensure reference consistency (some journal names italicized, others not). o Add DOIs for all references where possible. o A few references (e.g., “Tissue Processing Systems Market...”) are non-peer-reviewed and should be supported by primary sources if available. The status of the paper is ongoing. o Include one or two recent citations (2023–2025) on open-source lab automation to contextualize innovation. Overall Assessment • Strengths: o High reproducibility and transparency (open-source design, detailed methods). o Excellent integration of engineering and biological applications. o Figures and methods are well structured and clear. • Weaknesses & Improvements: o Limited statistical validation and quantitative comparison. o Some redundancy across sections (especially Abstract vs. Conclusion). o “DIY” phrasing may reduce perceived technical rigor. o Lack of discussion on safety, error handling, and scalability. Reviewer #3: Imaging techniques are not only used to examine the cell growth and responses but also to examine cell death. Therefore, please add this information under the introduction part. Also work on the grammatical and editorial corrections. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Dr. Hussen Abdu Muhidin Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 1 |
|
Design and evaluation of a low-cost, DIY programmable tissue processor for solvent exchange in biological sample preparation PONE-D-25-48079R1 Dear Dr. Bacheva and co-authors, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Fentahun Adane Nigat, MSc., PhD Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: I thank the authors for their rigorous revision. My comments were fully addressed. I think the revised manuscript was ready for publication. Reviewer #2: I would like to thank the authors for their commitment to address all of the comments I have given to them. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Dr. Hussen Abdu Muhidin ********** |
| Formally Accepted |
|
PONE-D-25-48079R1 PLOS One Dear Dr. Bacheva, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Fentahun Adane Nigat Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .